Complete lipiodol retention (N = 21) | Incomplete lipiodol retention (N = 9) | P value | ||
---|---|---|---|---|
Final progression status | No recurrence | 16 (76.2%) | 1 (11.1%) | 0.001 |
Recurrence | 5 (23.8%) | 8 (88.9%) | ||
Time from cTACE to recurrence (months) | Mean ± SD | 5.57 ± 2.69 | 6.0 ± 2.27 | 0.743 |
Range | 3–9 | 3–9 |